21st North (OTCMKTS:ULGX) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, institutional ownership, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for 21st North and Rockwell Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
21st North 0 0 0 0 N/A
Rockwell Medical 0 0 0 1 4.00

Rockwell Medical has a consensus target price of $11.00, indicating a potential upside of 112.77%. Given Rockwell Medical’s higher probable upside, analysts plainly believe Rockwell Medical is more favorable than 21st North.

Volatility and Risk

21st North has a beta of 4.94, indicating that its stock price is 394% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 2.12, indicating that its stock price is 112% more volatile than the S&P 500.

Institutional and Insider Ownership

19.0% of Rockwell Medical shares are owned by institutional investors. 8.5% of 21st North shares are owned by insiders. Comparatively, 18.2% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares 21st North and Rockwell Medical’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
21st North N/A N/A N/A N/A N/A
Rockwell Medical $63.39 million 4.70 -$32.13 million ($0.47) -11.11

21st North has higher earnings, but lower revenue than Rockwell Medical.

Profitability

This table compares 21st North and Rockwell Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
21st North N/A N/A N/A
Rockwell Medical -52.23% -121.54% -55.60%

Summary

Rockwell Medical beats 21st North on 5 of the 9 factors compared between the two stocks.

21st North Company Profile

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.

Rockwell Medical Company Profile

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Receive News & Ratings for 21st North Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 21st North and related companies with MarketBeat.com's FREE daily email newsletter.